Search for: "ACTELION PHARMACEUTICALS LTD"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
7 Dec 2023, 9:59 pm
The issue arose recently before the Federal Circuit in Actelion Pharmaceuticals Ltd. v. [read post]
11 Feb 2018, 9:58 pm
In particular, the Federal Circuit determined that the District Court did not err in affirming the USPTO's finding that Actelion failed to make an express request for early examination of the '619 application, as required by 35 U.S.C. [read post]
6 Nov 2023, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Actelion Pharmaceuticals Ltd. v. [read post]
6 Nov 2023, 1:15 pm
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Actelion Pharmaceuticals Ltd. v. [read post]
14 Jan 2024, 9:29 pm
Cir. 2023)*Actelion Pharmaceuticals Ltd. v. [read post]
14 Apr 2021, 2:01 pm
Baltimore claims Actelion Pharmaceuticals Ltd. [read post]
2 Jan 2024, 8:45 pm
Cir. 2023)Actelion Pharmaceuticals Ltd. v. [read post]
19 Apr 2021, 9:37 am
Circuit Court of Appeals on Tuesday revived a proposed class action against Janssen’s Actelion Pharmaceuticals Ltd accusing the company of extending its patent monopoly on its pulmonary artery hypertension drug Tracleer past the patent’s expiration date. [read post]
6 Nov 2023, 8:35 am
by Dennis Crouch Actelion Pharmaceuticals Ltd v. [read post]
1 Dec 2017, 11:35 am
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
10 Aug 2011, 4:30 am
Lupin Ltd. et al. [read post]
5 Aug 2009, 7:59 am
EPO - Get your house in order - understand how applications have changed over the last 12 months, and how your company needs to adapt to gain first time patent approval 2009 confirmed speakers include: Bo Hammer Janssen, Senior Patent Counsel, Novozymes Nicolas Ruiz, Head of IP, Esteve Dr Mandar Kodgule, Head, Intellectual Property and Strategic Planning, Wockhardt Ltd Dr William Heggie, CSO, Hovione James Horgan, Assistant Counsel, Merck, Sharpe & Dohme Ltd Dr… [read post]
13 Mar 2017, 1:39 am
On May 12, 2015, Actelion Pharmaceuticals Ltd filed a cancellation action against the Swiss part of EP 1 200 092 of Lilly ICOS LLC and requested that the patent in question be deleted. [read post]
9 Jul 2015, 4:01 am
In its reasoning, the court characterized fees as simply administrative (arguably in contrast to the result in Dutch Industries): 32 The purpose of such fees, as has been stated by the Federal Court of Appeal in Actelion Pharmaceuticals Ltd v Canada, 2008 FCA 90 at paragraph 13, is not only to provide the Patent Office with a means of recovering administration costs, but also to rid the proliferation of deadwood patents. [read post]
27 Jan 2020, 5:26 pm
This year, seven drug manufacturers – Actelion Pharmaceuticals US Inc. [read post]
